World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
146
Citations
69689
World Ranking
1348
National Ranking
785

Research.com Recognitions

  • 1997 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Joseph H. Antin is affiliated with the Dana-Farber Cancer Institute in the United States. Their research primarily focuses on medicine, with extensive contributions to hematology, genetics, immunology, oncology, and public health, environmental and occupational health.

The scientist has a significant body of work within the field of hematopoietic stem cell transplantation. Key research topics also include acute myeloid leukemia research, immune cell function and interaction, acute lymphoblastic leukemia research, polyomavirus and related diseases, myeloproliferative neoplasms diagnosis and treatment, and chronic myeloid leukemia treatments.

Joseph H. Antin has published numerous papers in prominent venues. Frequent publication outlets include:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Journal of Clinical Oncology
  • UNC Libraries

Notable recent papers include:

  • "Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial", 2020, Blood
  • "HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis", 2021, Blood
  • "Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide", 2021, Blood Advances
  • "GVHD Prophylaxis 2020", 2021, Frontiers in Immunology
  • "Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial", 2022, The Lancet Haematology

The scientist collaborates frequently with several coauthors, including:

  • Corey Cutler
  • Robert J. Soiffer
  • Mahasweta Gooptu
  • Vincent T. Ho
  • Sarah Nikiforow

Joseph H. Antin's work encompasses comprehensive studies of hematopoietic cell transplantation strategies, immune reconstitution, and transplant-related complications. Their research contributions address key issues related to donor selection, prophylaxis after transplantation, and outcomes for patients with hematologic conditions.

In recognition of career achievements, Joseph H. Antin was named a Fellow of the American Association for the Advancement of Science (AAAS) in 1997.

Best Publications

  • Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

    R H Collins;O Shpilberg;W R Drobyski;D L Porter

  • Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough

  • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

    John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda

  • Cytokine dysregulation and acute graft-versus-host disease.

    J. H. Antin;J. L. M. Ferrara

  • Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.

    Thomas R. Ziegler;Lorraine S. Young;Kathleen Benfell;Marc Scheltinga

  • Cholecystokinin elicits the complete behavioral sequence of satiety in rats.

    Joseph Antin;James Gibbs;Jonathan Holt;Robert C. Young

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang

  • Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

    Craig Kollman;Craig W. S. Howe;Claudio Anasetti;Joseph H. Antin

  • Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

    Richard A. Nash;Joseph H. Antin;Chatchada Karanes;Joseph W. Fay

  • Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

    R Coleman Lindsley;Wael Saber;Brenton G Mar;Robert Redd

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.

    David L. Porter;Mark S. Roth;Carol McGarigle;James Ferrara

  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

    Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  • Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

    Jason A. Coppell;Paul G. Richardson;Robert Soiffer;Paul L. Martin

  • Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

    Stephanie J. Lee;John P. Klein;A. John Barrett;Olle Ringden

  • Contribution of bone marrow-derived endothelial cells to human tumor vasculature

    Brock A Peters;Luis A Diaz;Kornelia Polyak;Leslie Meszler

  • Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

    Ann M. Leen;Catherine M. Bollard;Adam M. Mendizabal;Elizabeth J. Shpall

  • Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis

    Corey Cutler;Satyendra Giri;Suriya Jeyapalan;David Paniagua

Frequent Co-Authors

Robert J. Soiffer
Robert J. Soiffer Harvard University
Corey Cutler
Corey Cutler Harvard University
Vincent T. Ho
Vincent T. Ho Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
Jerome Ritz
Jerome Ritz Harvard University
John Koreth
John Koreth Harvard University
Haesook T. Kim
Haesook T. Kim Harvard University
Philippe Armand
Philippe Armand Harvard University
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of medicine in the USA offers many alternative career pathways and online degree options for those seeking flexibility and growth. If you are interested in healthcare roles that don’t require medical school, there are accessible options to consider. For example, medical coding and billing classes online with financial aid can provide entry into vital administrative positions in healthcare, often with minimal prerequisites.

Aspiring nurses may benefit from programs tailored for easy entry. Some lpn school without teas test requirements allow you to get started quickly, bypassing standardized entrance exams.

Those looking to move into healthcare management roles should explore options like accelerated healthcare administration degree online programs. These can prepare you for leadership positions in hospitals and clinics more efficiently.

Nurses wanting to advance their education might consider specialized bridge programs such as asn to np programs, which help registered nurses rapidly earn advanced practitioner qualifications.

Together, these flexible and affordable online options open doors for non-traditional students and those seeking career advancement in healthcare.

Best Scientists Citing Joseph H. Antin

Trending Scientists